Gerry Oster, PhD

Articles

September 17th 2014

Is All "Skin in the Game" Fair Game? The Problem With "Non-Preferred" Generics

The authors comment on the growth of drug plans with tiers for "non-preferred" generics, and argue that most are inconsistent with established principles of formulary design.

September 13th 2010

Benefits and Risks of Live Attenuated Influenza Vaccine in Young Children

Gerry Oster, PhD Derek Weycker, PhD John Edelsberg, MD, MPH Kristin L. Nichol, MD, MPH Jerome O. Klein, MD Robert B. Belshe, MD

Use of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.

May 28th 2010

Patterns of Healthcare Utilization and Cost in Patients With Newly Diagnosed Fibromyalgia

Ariel Berger, MPH Alesia Sadosky, PhD, MPH, MBA Ellen M. Dukes, PhD John Edelsberg, MD, MPH Gergana Zlateva, PhD Gerry Oster, PhD

August 7th 2009

Cost Comparison of Peritoneal Dialysis Versus Hemodialysis in End-Stage Renal Disease

Ariel Berger, MPH John Edelsberg, MD, MPH Gary W. Inglese, RN, MBA Samir K. Bhattacharyya, PhD Gerry Oster, PhD

Patients with end-stage renal disease who began peritoneal dialysis had lower 1-year hospitalization rates and lower total healthcare costs than those who began therapy with hemodialysis.

July 1st 2000

Childhood Vaccination Against Pneumococcal Otitis Media and Pneumonia: An Analysis of Benefits and Costs

Derek Weycker, PhD Erin Richardson, BA Gerry Oster, PhD

June 1st 2000

The Clinical and Economic Burden of Obesity in a Managed Care Setting

Gerry Oster, PhD John Edelsberg, MD, MPH Amy K. O'Sullivan, BA David Thompson, PhD

October 1st 1996

Patterns of Antidepressant Use and Their Relation to Costs of Care

David Thompson, PhD Don Buesching, PhD Karl J. Gregor, PharmD, MS Gerry Oster, PhD